Want to see PAIYY full AI Analyst Report?
Top Page
Aesthetic Medical International Holdings Group
(OTC:PAIYY)
Select Model
Select Model
Rating:41Neutral
Price Target:
$0.08
▲(275.00% Upside)
Action:Upgraded
Date:06/24/26
The score is primarily constrained by weak financial performance (widening losses, negative operating/free cash flow in 2025, rising debt, and negative equity). Technical indicators add risk with a negative MACD and price below longer-term averages, while valuation provides limited support due to a negative P/E and no dividend yield.
Positive Factors
Gross margin strength
Sustained gross margins in the mid‑40s to low‑50s indicate the core service offering retains pricing power and cost advantage. That margin buffer can absorb some SG&A volatility and supports a path to operating leverage if revenue stabilizes.
Negative Factors
Deteriorated balance sheet
Rising debt alongside negative shareholders' equity materially reduces financial flexibility and increases insolvency risk. Negative equity limits the company's ability to absorb further losses, raises creditor scrutiny, and constrains strategic options over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Gross margin strength
Sustained gross margins in the mid‑40s to low‑50s indicate the core service offering retains pricing power and cost advantage. That margin buffer can absorb some SG&A volatility and supports a path to operating leverage if revenue stabilizes.
Read all positive factors
Aesthetic Medical International Holdings Group (PAIYY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$827.69K
Dividend YieldN/A
Average Volume (3M)118.00
Price to Earnings (P/E)―
Beta (1Y)-2.89
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees1,139
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)N/A
Shares Outstanding48,687,584
10 Day Avg. Volume200
30 Day Avg. Volume118
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.90
Price to Sales (P/S)0.03
P/FCF Ratio-0.80
Enterprise Value/Market Cap<0.01
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Aesthetic Medical International Holdings Group Business Overview & Revenue Model
Company Description
Aesthetic Medical International Holdings Group Ltd. engages in the provision of aesthetic medical services. It offers surgical and non-surgical treatments, cosmetic dentistry, and general healthcare services. The firm's treatments include eye surg...
How the Company Makes Money
null...
Aesthetic Medical International Holdings Group Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
18
Very Negative
Cash Flow
27
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Mar 2023 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 703.16M | 755.67M | 682.59M | 670.09M | 645.59M |
| Gross Profit | 325.14M | 337.79M | 322.05M | 355.59M | 269.50M |
| EBITDA | 62.38M | 73.33M | 25.31M | -11.05M | -554.95M |
| Net Income | -51.89M | -19.95M | -37.43M | -76.25M | -586.62M |
Balance Sheet | |||||
| Total Assets | 511.22M | 486.22M | 560.66M | 546.37M | 576.94M |
| Cash, Cash Equivalents and Short-Term Investments | 65.40M | 42.84M | 62.34M | 12.16M | 39.29M |
| Total Debt | 280.76M | 179.30M | 244.55M | 393.10M | 405.91M |
| Total Liabilities | 554.48M | 476.88M | 527.03M | 672.25M | 763.36M |
| Stockholders Equity | -20.61M | 30.46M | 48.89M | -113.66M | -156.67M |
Cash Flow | |||||
| Free Cash Flow | -23.01M | 48.88M | 18.83M | -76.80M | 17.65M |
| Operating Cash Flow | -16.29M | 79.67M | 74.29M | -75.13M | 51.09M |
| Investing Cash Flow | -405.63K | -30.32M | -52.25M | 3.11M | -11.53M |
| Financing Cash Flow | 37.62M | -68.55M | 29.06M | 45.55M | -45.23M |
Aesthetic Medical International Holdings Group Technical Analysis
Positive
0.02
Price Trends
0.02
Positive
0.03
Positive
0.06
Positive
Market Momentum
<0.01
Negative
99.35
Negative
16.41
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PAIYY, the sentiment is Positive. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.02, and below the 200-day MA of 0.06, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 99.35 is Negative, neither overbought nor oversold. The STOCH value of 16.41 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PAIYY.
Aesthetic Medical International Holdings Group Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
55 Neutral | $11.74M | -0.86 | -358.44% | ― | -0.71% | 58.20% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | $5.99M | -0.36 | -41.95% | ― | ― | 99.50% | |
41 Neutral | $827.69K | -0.03 | -1054.33% | ― | ― | ― | |
37 Underperform | $1.37M | -0.02 | -198.37% | ― | -7.16% | 71.12% |
* Healthcare Sector Average
PAIYY
Aesthetic Medical International Holdings Group
0.08
-0.11
-58.46%
NCNA
Nucana
1.43
-1.43
-50.00%
CELZ
Creative Medical Technology Holdings
1.06
-2.23
-67.78%
HSCS
Heart Test Laboratories, Inc.
3.36
0.03
0.90%
TNMG
TNL Mediagene
0.45
-6.00
-92.99%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.